Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bench

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Psychopharmacology|March 1, 1996
The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomographyC J Bench, A A Lammertsma, P M Grasby, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatmentR Alexander Bantick, Andrew J Montgomery, Christopher J Bench, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
A Polycythemia Vera Updated: Diagnosis, Pathobiology, and TreatmentThomas C. Pearson, Maria Messinezy, Nigel Westwood, et al.
Plant Physiology|August 19, 2011
A large-scale genetic screen in Arabidopsis to identify genes involved in pollen exine productionAnna A Dobritsa, Aliza Geanconteri, Jay Shrestha, et al.
Neuroimage|November 13, 1998
Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PETR N Gunn, P A Sargent, C J Bench, et al.
Psychopharmacology|January 1, 1993
Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-racloprideC J Bench, A A Lammertsma, R J Dolan, et al.
Neuroimage|February 19, 2002
A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variablesEugenii A Rabiner, Cristina Messa, Peter A Sargent, et al.
European Journal of Pharmacology|September 5, 1995
First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635V W Pike, J A McCarron, A A Lammerstma, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Genomics|June 6, 1998
A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted regionA J Bench, M A Aldred, S J Humphray, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Psychopharmacology|March 1, 1996
The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomographyC J Bench, A A Lammertsma, P M Grasby, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatmentR Alexander Bantick, Andrew J Montgomery, Christopher J Bench, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
A Polycythemia Vera Updated: Diagnosis, Pathobiology, and TreatmentThomas C. Pearson, Maria Messinezy, Nigel Westwood, et al.
Plant Physiology|August 19, 2011
A large-scale genetic screen in Arabidopsis to identify genes involved in pollen exine productionAnna A Dobritsa, Aliza Geanconteri, Jay Shrestha, et al.
Neuroimage|November 13, 1998
Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PETR N Gunn, P A Sargent, C J Bench, et al.
Psychopharmacology|January 1, 1993
Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and 11C-racloprideC J Bench, A A Lammertsma, R J Dolan, et al.
Neuroimage|February 19, 2002
A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variablesEugenii A Rabiner, Cristina Messa, Peter A Sargent, et al.
European Journal of Pharmacology|September 5, 1995
First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635V W Pike, J A McCarron, A A Lammerstma, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.
Genomics|June 6, 1998
A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted regionA J Bench, M A Aldred, S J Humphray, et al.
Pageof 14